These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. The search for viable myocardium. Bonow RO West J Med; 1996 Dec; 165(6):393-6. PubMed ID: 9000868 [No Abstract] [Full Text] [Related]
47. Multifactorial determination of 201thallium uptake of the heart: an experimental study concerning the influence of ventricular mass, perfusion and oxygen consumption. Strauer BE; Bürger S; Büll U Basic Res Cardiol; 1978; 73(3):298-306. PubMed ID: 687324 [TBL] [Abstract][Full Text] [Related]
48. Role of FDG-PET in Evaluation of Myocardial Viability. Molchanova-Cook O; Chen W PET Clin; 2011 Oct; 6(4):383-91. PubMed ID: 27156872 [TBL] [Abstract][Full Text] [Related]
49. Is ischemia the most powerful indicator of myocardial viability? Shirani J Curr Cardiol Rep; 2013 May; 15(5):354. PubMed ID: 23512623 [TBL] [Abstract][Full Text] [Related]
50. Myocardial viability testing: all STICHed up, or about to be REVIVED? Ryan M; Morgan H; Chiribiri A; Nagel E; Cleland J; Perera D Eur Heart J; 2022 Jan; 43(2):118-126. PubMed ID: 34791132 [TBL] [Abstract][Full Text] [Related]
51. [Considerations on myocardial scintigraphy with 201thallium after stress]. Albano T; Antonini M; Biasia R; Bobba F; Ciambellotti E; Jon G; Torta D Minerva Med; 1979 Nov; 70(50):3447-60. PubMed ID: 503362 [TBL] [Abstract][Full Text] [Related]
52. [Thallium scintigraphy of the myocardium. I. Principles and methods]. Lepej J; Farský S Cesk Radiol; 1990 May; 44(3):171-8. PubMed ID: 2372845 [TBL] [Abstract][Full Text] [Related]
53. Editorial commentary: Is it still important to evaluate patients with ischemic cardiomyopathy for viable dysfunctional myocardium prior to myocardial revascularization? Canty JM Trends Cardiovasc Med; 2018 Jan; 28(1):38-40. PubMed ID: 28863971 [No Abstract] [Full Text] [Related]
54. Cardiac MRI and Ischemic Heart Disease: Role in Diagnosis and Risk Stratification. Sawlani RN; Collins JD Curr Atheroscler Rep; 2016 May; 18(5):23. PubMed ID: 26980317 [TBL] [Abstract][Full Text] [Related]
55. Heart damage in thyrotoxicosis and implication of ischemic disease of the heart - questions about pathogenesis, diagnosis and treatment. Felt V Czech Med; 1983; 6(3):175-7. PubMed ID: 6416795 [No Abstract] [Full Text] [Related]
56. [Essential aspects of differential diagnosis of coronarogenic and non-coronarogenic myocardial lesions]. Gurevich MA; Zaman S; Gordienko BV Klin Med (Mosk); 1997; 75(4):28-32. PubMed ID: 9229628 [No Abstract] [Full Text] [Related]
57. Clinical assessment of regional function: strengths and limitations. Quiñones MA Coron Artery Dis; 1995 Aug; 6(8):625-8. PubMed ID: 8574457 [No Abstract] [Full Text] [Related]
58. Nuclear cardiology. Jolobe O J R Coll Physicians Lond; 1999; 33(1):94-5. PubMed ID: 10192081 [No Abstract] [Full Text] [Related]
59. Myocardial imaging in the evaluation of patients with ischemic heart disease. Pitt B; Strauss HW Md State Med J; 1976 Mar; 25(3):69. PubMed ID: 1256079 [No Abstract] [Full Text] [Related]